
HealthCor Partners
Description
HealthCor Partners Management, L.P., commonly known as HealthCor Partners, is a distinguished private equity firm based in Charleston, United States, dedicated to growth equity investments within the healthcare sector. Operating as the private equity arm of HealthCor Management, L.P., the firm strategically targets commercial-stage healthcare companies that have demonstrated proven products or services and are poised for significant expansion. Their investment philosophy centers on providing substantial capital to accelerate growth, enhance market penetration, and support strategic initiatives for their portfolio companies.
The firm's investment strategy spans a broad range of healthcare sub-sectors, including biotechnology, medical devices, pharmaceuticals, and healthcare services. HealthCor Partners typically seeks to acquire significant minority or control positions, indicating a hands-on approach to value creation. Their typical first cheque size for new investments ranges from $25 million to $75 million per transaction. This substantial investment range underscores their focus on later-stage growth equity rounds, differentiating them from early-stage venture capital firms and enabling them to provide the necessary capital for companies to scale operations, expand product lines, or enter new markets.
HealthCor Partners has successfully raised considerable capital, affirming its strong presence in the healthcare investment landscape. The firm closed its inaugural fund, HealthCor Partners Fund, L.P., with $500 million in commitments in 2014. Building on this foundation, they subsequently closed their second fund, HealthCor Partners II, L.P., at $750 million in 2018, bringing their total capital raised across these two funds to $1.25 billion. These significant fund sizes allow HealthCor Partners to be a leading investor in the healthcare growth equity space, supporting a diverse portfolio of companies through their commercial development and contributing to successful exits, as seen with companies like Intersect ENT and Silk Road Medical.
Investor Profile
HealthCor Partners has backed more than 20 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 10% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, France, Canada.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $25M – $75M.
Stage Focus
- Series Unknown (25%)
- Series B (20%)
- Series C (10%)
- Post Ipo Equity (10%)
- Series F (10%)
- Series D (5%)
- Seed (5%)
- Post Ipo Debt (5%)
- Series E (5%)
- Convertible Note (5%)
Country Focus
- United States (85%)
- France (5%)
- Canada (5%)
- United Kingdom (5%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Health Diagnostics
- Pharmaceutical
- Artificial Intelligence (Ai)
- Manufacturing
- Oncology
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.